In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report ...

In response to a recent article about an interesting biotechnology stock, a reader recently asked me how to handle the ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...

Clinical trials start with early discovery and ongoing research. After approval by the FDA, the research goes through the following phases. Patient participants are essential to clinical trials. Ask ...

Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial ...

Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...

In China, a vaccine candidate typically goes through three phases of clinical trials before gaining ... Another mpox vaccine candidate under research is developed by the Shanghai Institute of ...

CX-801 is under development for the treatment of metastatic solid tumors including metastatic melanoma, metastatic renal cell carcinoma (RCC) and head and neck squamous cell carcinoma (HNSCC). It is a ...